Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


21.08.2017

1 Cancer
1 Cancer Lett
1 J Am Acad Dermatol
2 Melanoma Res
1 PLoS Genet


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Cancer

  1. SHIELD PW, Frost F, Finnimore JL, Wright RG, et al
    External quality assurance in nongynecologic cytology: The Australasian experience.
    Cancer. 2017;125:349-361.
    PubMed     Text format     Abstract available


    Cancer Lett

  2. WANG J, Hirose H, Du G, Chong K, et al
    P-REX1 amplification promotes progression of cutaneous melanoma via the PAK1/P38/MMP-2 pathway.
    Cancer Lett. 2017 Aug 10. pii: S0304-3835(17)30478.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  3. NAVARRETE-DECHENT C, Del Puerto C, Molgo M, Gonzalez S, et al
    Circulating vitamin D-binding protein and free 25-hydroxyvitamin D concentrations in patients with melanoma: A case-control study.
    J Am Acad Dermatol. 2017;77:575-577.
    PubMed     Text format    


    Melanoma Res

  4. GLITZA IC, Guha-Thakurta N, D'Souza NM, Amaria RN, et al
    Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases.
    Melanoma Res. 2017 Aug 16. doi: 10.1097/CMR.0000000000000389.
    PubMed     Text format     Abstract available

  5. PURI A, Homsi J
    The safety of pembrolizumab in metastatic melanoma and rheumatoid arthritis.
    Melanoma Res. 2017 Aug 16. doi: 10.1097/CMR.0000000000000387.
    PubMed     Text format     Abstract available


    PLoS Genet

  6. SCAHILL CM, Digby Z, Sealy IM, Wojciechowska S, et al
    Loss of the chromatin modifier Kdm2aa causes BrafV600E-independent spontaneous melanoma in zebrafish.
    PLoS Genet. 2017;13:e1006959.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: